ADVANCED SALIVARY GLAND CARCINOMA
Clinical trials for ADVANCED SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat HER2 cancers
Disease control OngoingThis early-phase trial is testing a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (a drug that may block cancer cell repair)—in people with advanced solid tumors that have a HER2 mutation. The study has two parts: first, finding the sa…
Matched conditions: ADVANCED SALIVARY GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Personalized drug attack on salivary gland tumors shows promise
Disease control OngoingThis study tests whether giving targeted drugs based on the genetic makeup of a person's advanced salivary gland cancer can shrink tumors or stop them from growing. About 88 adults with cancer that has spread or come back are enrolled. Researchers are checking how well these trea…
Matched conditions: ADVANCED SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC